Molecular Templates, Inc. (NASDAQ:MTEM) Major Shareholder Sells $844,681.20 in Stock

Molecular Templates, Inc. (NASDAQ:MTEM) major shareholder Target N. V. Biotech sold 1,279,820 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $0.66, for a total transaction of $844,681.20. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Molecular Templates Price Performance

Shares of NASDAQ MTEM traded down $0.01 during trading on Monday, reaching $0.45. 10,064,368 shares of the stock traded hands, compared to its average volume of 2,838,425. The stock has a market capitalization of $2.98 million, a P/E ratio of -0.17 and a beta of 1.22. The company has a 50-day moving average of $0.91 and a 200-day moving average of $1.21. Molecular Templates, Inc. has a 52-week low of $0.30 and a 52-week high of $5.37.

About Molecular Templates

Molecular Templates, Inc, a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB).